BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dupont RL, Mclellan AT, White WL, Merlo LJ, Gold MS. Setting the standard for recovery: Physicians' Health Programs. Journal of Substance Abuse Treatment 2009;36:159-71. [DOI: 10.1016/j.jsat.2008.01.004] [Cited by in Crossref: 100] [Cited by in F6Publishing: 67] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Weenink JW, Kool RB, Hesselink G, Bartels RH, Westert GP. Prevention of and dealing with poor performance: an interview study about how professional associations aim to support healthcare professionals. Int J Qual Health Care 2017;29:838-44. [PMID: 29024984 DOI: 10.1093/intqhc/mzx114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Merlo LJ, Greene WM, Pomm R. Mandatory naltrexone treatment prevents relapse among opiate-dependent anesthesiologists returning to practice. J Addict Med 2011;5:279-83. [PMID: 22107877 DOI: 10.1097/ADM.0b013e31821852a0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
3 Earley PH, Zummo J, Memisoglu A, Silverman BL, Gastfriend DR. Open-label Study of Injectable Extended-release Naltrexone (XR-NTX) in Healthcare Professionals With Opioid Dependence. J Addict Med 2017;11:224-30. [PMID: 28358754 DOI: 10.1097/ADM.0000000000000302] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
4 DuPont RL, Compton WM, McLellan AT. Five-Year Recovery: A New Standard for Assessing Effectiveness of Substance Use Disorder Treatment. J Subst Abuse Treat 2015;58:1-5. [PMID: 26277423 DOI: 10.1016/j.jsat.2015.06.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
5 Gold MS, Baron D, Bowirrat A, Blum K. Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? J Neurol Sci 2020;418:117137. [PMID: 32957037 DOI: 10.1016/j.jns.2020.117137] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Light KE, Goodner K, Seaton VA, Boyle B, Hopkins R. State programs assisting pharmacy professionals with substance use disorders. J Am Pharm Assoc (2003) 2017;57:704-10. [PMID: 28807661 DOI: 10.1016/j.japh.2017.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Srivastava AB, Gold MS. Beyond Supply: How We Must Tackle the Opioid Epidemic. Mayo Clin Proc 2018;93:269-72. [PMID: 29502558 DOI: 10.1016/j.mayocp.2018.01.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
8 Oreskovich MR, Shanafelt T, Dyrbye LN, Tan L, Sotile W, Satele D, West CP, Sloan J, Boone S. The prevalence of substance use disorders in American physicians: The Prevalence of Substance Use Disorders in American. Am J Addict 2015;24:30-8. [DOI: 10.1111/ajad.12173] [Cited by in Crossref: 147] [Cited by in F6Publishing: 107] [Article Influence: 24.5] [Reference Citation Analysis]
9 Myers MF, Freeland A. The Mentally Ill Physician: Issues in Assessment, Treatment and Advocacy. Can J Psychiatry 2019;64:823-37. [PMID: 31430184 DOI: 10.1177/0706743719856002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Merlo LJ, Greene WM. Physician views regarding substance use-related participation in a state physician health program. Am J Addict 2010;19:529-33. [PMID: 20958849 DOI: 10.1111/j.1521-0391.2010.00088.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
11 Zuleta-Alarcón A, Coffman JC, Soghomonyan S, Papadimos TJ, Bergese SD, Moran KR. Non-opioid anesthetic drug abuse among anesthesia care providers: a narrative review. Can J Anaesth 2017;64:169-84. [PMID: 27470230 DOI: 10.1007/s12630-016-0698-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
12 Strang J, Babor T, Caulkins J, Fischer B, Foxcroft D, Humphreys K. Drug policy and the public good: evidence for effective interventions. Lancet 2012;379:71-83. [PMID: 22225672 DOI: 10.1016/S0140-6736(11)61674-7] [Cited by in Crossref: 138] [Cited by in F6Publishing: 35] [Article Influence: 15.3] [Reference Citation Analysis]
13 Welcher CM, Radabaugh CL, Aparicio A, Chaudhry HJ, Staz ML, Kirk LM, Bresnahan L. Programs and Resources to Alleviate Concerns with Mental Health Disclosures on Physician Licensing Applications. Journal of Medical Regulation 2019;105:24-32. [DOI: 10.30770/2572-1852-105.2.24] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Braquehais MD, Nieva G, González-Irizar O, Mozo X, Valero S, Bruguera E. Family physicians with mental disorders admitted to a physicians' health programme: what can be learned? Fam Pract 2020;37:655-60. [PMID: 32270191 DOI: 10.1093/fampra/cmaa031] [Reference Citation Analysis]
15 Merlo LJ, Campbell MD, Skipper GE, Shea CL, DuPont RL. Outcomes for Physicians With Opioid Dependence Treated Without Agonist Pharmacotherapy in Physician Health Programs. J Subst Abuse Treat 2016;64:47-54. [PMID: 26971079 DOI: 10.1016/j.jsat.2016.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
16 Patterson Silver Wolf DA, Gold M. Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations. J Neurol Sci 2020;411:116718. [PMID: 32078842 DOI: 10.1016/j.jns.2020.116718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
17 McKay JR, Knepper C, Deneke E, O'Reilly C, DuPont RL. An Initial Evaluation of a Comprehensive Continuing Care Intervention for Clients with Substance Use Disorders: My First Year of Recovery (MyFYR). J Subst Abuse Treat 2016;67:50-4. [PMID: 27296662 DOI: 10.1016/j.jsat.2016.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
18 Smith DE. Medicalizing the Opioid Epidemic in the U.S. in the Era of Health Care Reform. J Psychoactive Drugs 2017;49:95-101. [PMID: 28296623 DOI: 10.1080/02791072.2017.1295334] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
19 DuPont RL, Merlo LJ, Arria AM, Shea CL. Random student drug testing as a school-based drug prevention strategy. Addiction 2013;108:839-45. [PMID: 22906236 DOI: 10.1111/j.1360-0443.2012.03978.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
20 Hamza H, Bryson EO. Buprenorphine maintenance therapy in opioid-addicted health care professionals returning to clinical practice: a hidden controversy. Mayo Clin Proc 2012;87:260-7. [PMID: 22386182 DOI: 10.1016/j.mayocp.2011.09.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
21 Proctor SL, Herschman PL. The continuing care model of substance use treatment: what works, and when is "enough," "enough?". Psychiatry J 2014;2014:692423. [PMID: 24839597 DOI: 10.1155/2014/692423] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
22 Lawson ND, Boyd JW. Flaws in the methods and reporting of physician health program outcome studies. Gen Hosp Psychiatry 2018;54:65-6. [PMID: 29914651 DOI: 10.1016/j.genhosppsych.2018.06.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
23 Krill PR, Johnson R, Albert L. The Prevalence of Substance Use and Other Mental Health Concerns Among American Attorneys. J Addict Med 2016;10:46-52. [PMID: 26825268 DOI: 10.1097/ADM.0000000000000182] [Cited by in Crossref: 31] [Cited by in F6Publishing: 4] [Article Influence: 6.2] [Reference Citation Analysis]
24 Blum K, Han D, Femino J, Smith DE, Saunders S, Simpatico T, Schoenthaler SJ, Oscar-Berman M, Gold MS. Systematic evaluation of "compliance" to prescribed treatment medications and "abstinence" from psychoactive drug abuse in chemical dependence programs: data from the comprehensive analysis of reported drugs. PLoS One 2014;9:e104275. [PMID: 25247439 DOI: 10.1371/journal.pone.0104275] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
25 Jungerman FS, Palhares Alves HN, Carmona MJC, Conti NB, Malbergier A. Anesthetic Drug Abuse by Anesthesiologists. Brazilian Journal of Anesthesiology 2012;62:375-86. [DOI: 10.1016/s0034-7094(12)70138-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Silverman K, Holtyn AF, Morrison R. The Therapeutic Utility of Employment in Treating Drug Addiction: Science to Application. Transl Issues Psychol Sci 2016;2:203-12. [PMID: 27777966 DOI: 10.1037/tps0000061] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 5.2] [Reference Citation Analysis]
27 Brown AM, Bohler R. Achieving a 15% Relapse Rate: A Review of Collegiate Recovery and Physician Health Programs. Alcoholism Treatment Quarterly 2018;37:109-22. [DOI: 10.1080/07347324.2018.1424595] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
28 Geuijen PM, van den Broek SJM, Dijkstra BAG, Kuppens JM, de Haan HA, de Jong CAJ, Schene AH, Atsma F, Schellekens AFA. Success Rates of Monitoring for Healthcare Professionals with a Substance Use Disorder: A Meta-Analysis. J Clin Med 2021;10:E264. [PMID: 33450803 DOI: 10.3390/jcm10020264] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sudan R, Seymour K. The Impaired Surgeon. Surg Clin North Am. 2016;96:89-93. [PMID: 26612022 DOI: 10.1016/j.suc.2015.09.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
30 Dupont RL, Seppala MD, White WL. The three missing elements in the treatment of substance use disorders: Lessons from the physician health programs. Journal of Addictive Diseases 2015;35:3-7. [DOI: 10.1080/10550887.2015.1102797] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Blum K, Chen TJ, Downs BW, Bowirrat A, Waite RL, Braverman ER, Madigan M, Oscar-Berman M, DiNubile N, Stice E. Neurogenetics of dopaminergic receptor supersensitivity in activation of brain reward circuitry and relapse: proposing "deprivation-amplification relapse therapy" (DART). Postgrad Med. 2009;121:176-196. [PMID: 19940429 DOI: 10.3810/pgm.2009.11.2087] [Cited by in Crossref: 40] [Cited by in F6Publishing: 46] [Article Influence: 3.6] [Reference Citation Analysis]
32 Heather N. Is the concept of compulsion useful in the explanation or description of addictive behaviour and experience? Addict Behav Rep 2017;6:15-38. [PMID: 29450234 DOI: 10.1016/j.abrep.2017.05.002] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
33 Strobbe S, Crowley M. Substance Use Among Nurses and Nursing Students: A Joint Position Statement of the Emergency Nurses Association and the International Nurses Society on Addictions. UJAN 2017;28:104-6. [DOI: 10.1097/jan.0000000000000150] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
34 Degenhardt L, Stockings E, Strang J, Marsden J, Hall WD. Illicit Drug Dependence. In: Patel V, Chisholm D, Dua T, Laxminarayan R, Medina-mora ML, editors. Disease Control Priorities, Third Edition (Volume 4): Mental, Neurological, and Substance Use Disorders. The World Bank; 2016. pp. 109-25. [DOI: 10.1596/978-1-4648-0426-7_ch6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
35 Kunyk D. Substance use disorders among registered nurses: prevalence, risks and perceptions in a disciplinary jurisdiction. J Nurs Manag 2015;23:54-64. [DOI: 10.1111/jonm.12081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
36 Dupont RL, Humphreys K. A New Paradigm for Long-Term Recovery. Substance Abuse 2011;32:1-6. [DOI: 10.1080/08897077.2011.540497] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
37 Yuan K, Qin W, Liu J, Guo Q, Dong M, Sun J, Zhang Y, Liu P, Wang W, Wang Y, Li Q, Yang W, von Deneen KM, Gold MS, Liu Y, Tian J. Altered small-world brain functional networks and duration of heroin use in male abstinent heroin-dependent individuals. Neuroscience Letters 2010;477:37-42. [DOI: 10.1016/j.neulet.2010.04.032] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
38 Samuelson ST, Bryson EO. The impaired anesthesiologist: what you should know about substance abuse. Can J Anesth/J Can Anesth 2017;64:219-35. [DOI: 10.1007/s12630-016-0780-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
39 Dupont RL, Skipper GE. Six lessons from state physician health programs to promote long-term recovery. J Psychoactive Drugs 2012;44:72-8. [PMID: 22641968 DOI: 10.1080/02791072.2012.660106] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
40 Satel S, Lilienfeld SO. Addiction and the brain-disease fallacy. Front Psychiatry 2013;4:141. [PMID: 24624096 DOI: 10.3389/fpsyt.2013.00141] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 5.4] [Reference Citation Analysis]
41 Darbro N. Model Guidelines for Alternative Programs and Discipline Monitoring Programs. Journal of Nursing Regulation 2011;2:42-9. [DOI: 10.1016/s2155-8256(15)30301-x] [Cited by in Crossref: 13] [Article Influence: 1.3] [Reference Citation Analysis]
42 Meyer DJ, Price M. Peer review and psychiatric physician fitness for duty evaluations: analyzing the past and forecasting the future. Int J Law Psychiatry 2012;35:445-51. [PMID: 23122902 DOI: 10.1016/j.ijlp.2012.09.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Dupont RL. The opioid epidemic is an historic opportunity to improve both prevention and treatment. Brain Research Bulletin 2018;138:112-4. [DOI: 10.1016/j.brainresbull.2017.06.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
44 Kunyk D, Inness M, Reisdorfer E, Morris H, Chambers T. Help seeking by health professionals for addiction: A mixed studies review. Int J Nurs Stud 2016;60:200-15. [PMID: 27297381 DOI: 10.1016/j.ijnurstu.2016.05.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
45 Dennis ML, Scott CK. Four-year outcomes from the Early Re-Intervention (ERI) experiment using Recovery Management Checkups (RMCs). Drug Alcohol Depend 2012;121:10-7. [PMID: 21903347 DOI: 10.1016/j.drugalcdep.2011.07.026] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 4.2] [Reference Citation Analysis]
46 Kunyk D, Austin W. Nursing under the influence: a relational ethics perspective. Nurs Ethics 2012;19:380-9. [PMID: 21646324 DOI: 10.1177/0969733011406767] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
47 Earley PH. Opioid substitution therapy for dependent health care practitioners: approach with caution. Mayo Clin Proc 2012;87:803-4; author reply 806-8. [PMID: 22862867 DOI: 10.1016/j.mayocp.2012.06.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Dupont RL. Prescription Drug Abuse: An Epidemic Dilemma. Journal of Psychoactive Drugs 2010;42:127-32. [DOI: 10.1080/02791072.2010.10400685] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
49 Gold JA. Covid-19: adverse mental health outcomes for healthcare workers. BMJ 2020;369:m1815. [PMID: 32371465 DOI: 10.1136/bmj.m1815] [Cited by in Crossref: 55] [Cited by in F6Publishing: 41] [Article Influence: 55.0] [Reference Citation Analysis]
50 Monroe T, Hamza H, Stocks G, Scimeca PD, Cowan R. The misuse and abuse of propofol. Subst Use Misuse 2011;46:1199-205. [PMID: 21463203 DOI: 10.3109/10826084.2011.564705] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
51 Banasiewicz J, Zaręba K, Rozenek H, Ciebiera M, Jakiel G, Chylińska J, Owczarek K. Adaptive capacity of midwives participating in pregnancy termination procedures: Polish experience. Health Psychol Open 2020;7:2055102920973229. [PMID: 33343915 DOI: 10.1177/2055102920973229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Weenink J, Kool RB, Bartels RH, Westert GP. Getting back on track: a systematic review of the outcomes of remediation and rehabilitation programmes for healthcare professionals with performance concerns. BMJ Qual Saf 2017;26:1004-14. [DOI: 10.1136/bmjqs-2017-006710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
53 Lefebvre LG, Kaufmann IM. The identification and management of substance use disorders in anesthesiologists. Can J Anesth/J Can Anesth 2017;64:211-8. [DOI: 10.1007/s12630-016-0775-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.6] [Reference Citation Analysis]
54 Blum K, Gold MS. Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: A hypothesis. Medical Hypotheses 2011;76:576-84. [DOI: 10.1016/j.mehy.2011.01.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.8] [Reference Citation Analysis]
55 Caulkins JP, Dupont RL. Is 24/7 sobriety a good goal for repeat driving under the influence (DUI) offenders?: Editorial. Addiction 2010;105:575-7. [DOI: 10.1111/j.1360-0443.2009.02844.x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
56 Cottler LB, Ajinkya S, Merlo LJ, Nixon SJ, Ben Abdallah A, Gold MS. Lifetime psychiatric and substance use disorders among impaired physicians in a physicians health program: comparison to a general treatment population: psychopathology of impaired physicians. J Addict Med 2013;7:108-12. [PMID: 23412081 DOI: 10.1097/ADM.0b013e31827fadc9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 2.6] [Reference Citation Analysis]
57 Mallin R. Primary Care of the Patient in Recovery. Primary Care: Clinics in Office Practice 2011;38:137-42. [DOI: 10.1016/j.pop.2010.12.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
58 Hamou-Jennings FA, Dong C. Resilience training for healthcare providers: an Asian perspective. Mhealth 2016;2:25. [PMID: 28293600 DOI: 10.21037/mhealth.2016.06.01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Gunderman RB, Grogan K. Physician Impairment and Professionalism. American Journal of Roentgenology 2012;199:W543-4. [DOI: 10.2214/ajr.11.8146] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
60 Ross CA, Jakubec SL, Berry NS, Smye V. The business of managing nurses’ substance‐use problems. Nurs Inq 2019;27. [DOI: 10.1111/nin.12324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
61 Oesterle TS, Thusius NJ, Rummans TA, Gold MS. Medication-Assisted Treatment for Opioid-Use Disorder. Mayo Clin Proc 2019;94:2072-86. [PMID: 31543255 DOI: 10.1016/j.mayocp.2019.03.029] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
62 Braquehais MD, Tresidder A, Dupont RL. Service provision to physicians with mental health and addiction problems: . Current Opinion in Psychiatry 2015;28:324-9. [DOI: 10.1097/yco.0000000000000166] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
63 Silverman K, DeFulio A, Sigurdsson SO. Maintenance of reinforcement to address the chronic nature of drug addiction. Prev Med 2012;55 Suppl:S46-53. [PMID: 22668883 DOI: 10.1016/j.ypmed.2012.03.013] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
64 Boyd JW. A Call for National Standards and Oversight of State Physician Health Programs. Journal of Addiction Medicine 2015;9:431-2. [DOI: 10.1097/adm.0000000000000174] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
65 Goldenberg M D.O, Miotto K M.D, Skipper GE M.D, Sanford J B.A. Outcomes of Physicians with Substance Use Disorders in State Physician Health Programs: A Narrative Review. J Psychoactive Drugs 2020;52:195-202. [PMID: 32156222 DOI: 10.1080/02791072.2020.1734696] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
66 Polles AG, Williams MK, Phalin BR, Teitelbaum S, Merlo LJ. Neuropsychological impairment associated with substance use by physicians. Journal of the Neurological Sciences 2020;411:116714. [DOI: 10.1016/j.jns.2020.116714] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Boyd JW, Knight JR. Ethical and Managerial Considerations Regarding State Physician Health Programs. Journal of Addiction Medicine 2012;6:243-6. [DOI: 10.1097/adm.0b013e318262ab09] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 2.2] [Reference Citation Analysis]